Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation
Weinacht, Katja G., MD, PhD, Charbonnier, Louis-Marie, PhD, Alroqi, Fayhan, MD, Plant, Ashley, MD, Qiao, Qi, PhD, Wu, Hao, PhD, Ma, Clement, PhD, Torgerson, Troy R., MD, PhD, Rosenzweig, Sergio D., MD, PhD, Fleisher, Thomas A., MD, Notarangelo, Luigi D., MD, Hanson, Imelda C., MD, Forbes, Lisa R., MD, Chatila, Talal A., MD, MSc
Published in Journal of allergy and clinical immunology (01.05.2017)
Published in Journal of allergy and clinical immunology (01.05.2017)
Get full text
Journal Article